Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.
about
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactionsPreferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infectionTen years of Orthoclone OKT3 (muromonab-CD3): a reviewChorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virusA phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndromeNon-Hodgkin's lymphoma in rheumatoid arthritis.Donor transmitted and de novo cancer after liver transplantation.Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.Role of fine-needle aspiration in the clinical management of solid organ transplant recipients: a review.Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude miceFactors in the Development of Liver Transplantation.The immunocompromised patient and transfusion.Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings.Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.Liver transplantation in the ciclosporin era.Immunosuppression and other nonsurgical factors in the improved results of liver transplantation.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapyGeneration of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.The mother lode of liver transplantation, with particular reference to our new journal.Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.Pathogens in children with severe combined immune deficiency disease or AIDS.The surgical implications of the posttransplant lymphoproliferative disorders.Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infectionThe pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus diseasePost-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient originMolecular genetic analysis of lymphoid tumors arising after organ transplantation.The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridizationA survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphomaThe diagnosis of Epstein-Barr virus-associated polymorphic B cell lymphoma in immunocompromised patients: Review of methodsEpstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentEpstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation.Epstein-Barr virus and human diseases: recent advances in diagnosis
P2860
Q24614360-BAF62DAA-E819-46CA-BAE6-6CB6B59C1734Q24684237-A3E677E6-0D7F-448A-AF7B-6508E17DB690Q28241114-9748F861-51E0-40F1-92A9-64D6D268592FQ28345368-7310C3DA-621A-485F-A6E4-B53AE53003A5Q30496656-429F3658-BFA3-4B65-8BF7-3D4A06196D62Q33419517-F83E0165-FA85-43FA-9582-69B8F25582EDQ33563567-E26B4457-7769-4B4F-9FF8-D0E6A5F37E69Q33661124-43791849-A6A2-415F-9120-6E4331D7FA14Q33747600-EA50628A-988B-4A89-8E20-8EBEEE7663F4Q33760487-1E0C9F36-560B-447F-8FB9-BB9FF5B35940Q33841899-38E4B3D7-402D-4826-8D74-F6D2DA155457Q33993337-60515542-8330-4C45-8EFA-2D70A603020DQ34192814-0F097694-241D-470D-A8D6-BFC8E866105DQ34207259-1CFC8A60-782C-4915-B3E4-987F973E821FQ34220305-033E2342-AC0C-442F-A001-7E105F0AA6DAQ34235300-BCA660D2-5689-4B84-9104-3550ED178C45Q34244446-296F54F2-D86A-43F5-93C5-56ACB6717708Q34249381-B7C916FC-C8CA-4F90-85B6-7590B6D56D63Q34275290-89E858B8-7AE1-456C-A70C-8032E4F0A8D3Q34286455-050133BD-87E8-44AB-9DA2-D82F886D4239Q34302121-46C9BA60-0438-4224-9A18-841A1AB32A95Q34330092-7CEB856F-7839-40B4-9F72-EB53B70E5798Q34330594-89643B44-15B6-430E-8B66-721E4F9845D9Q34334755-9EBDF675-A3B7-4357-A798-98331E7BC60DQ34359339-6673B1BD-33E1-4EF9-98DF-A35CDB304472Q34427085-55D4B7A3-D010-46DA-B2C7-3AB2BB3B215EQ34728310-5DC4CBB7-E395-4A6E-B035-9C67D1148140Q34886639-C714B5F6-EC05-4956-8F41-A7537F996E69Q35160206-EFC54650-58F4-4F09-87C8-49D4AEE10216Q35683931-2128D0E9-17F9-4B3A-A57F-5F6BB272DA27Q35796427-CDC44DDB-F375-464E-B05F-7AFD4B07F00BQ35818174-0C48D5B6-15CA-455F-B2F8-17484418B243Q35818660-9CAE2E3F-643E-40A2-AFA8-8DD659ED073BQ35830350-72C129F3-254E-4539-A578-6436245199A7Q35831803-64D61BD4-7586-4B8A-8EDE-65FA31412BC2Q35831939-A0F934D5-A8B9-4A73-86C6-FAA0A9B15AEAQ35893186-8E790E3B-A6D8-4758-966E-1E357A912929Q36170494-417F8536-C791-4FE5-A077-3716E5E9C308Q36621820-3C8AD602-AD15-4F45-B765-15FADAADE0ADQ36633160-A4C93ED0-E3E4-4C6E-9147-E9B365949743
P2860
Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Epstein-Barr virus (EBV) induc ...... and implications for therapy.
@en
type
label
Epstein-Barr virus (EBV) induc ...... and implications for therapy.
@en
prefLabel
Epstein-Barr virus (EBV) induc ...... and implications for therapy.
@en
P2093
P1433
P1476
Epstein-Barr virus (EBV) induc ...... s and implications for therapy
@en
P2093
D C Arthur
G Frizzera
H H Balfour
J S Najarian
K J Gajl-Peczalska
R L Simmons
P304
P356
10.1097/00000658-198309000-00012
P407
P577
1983-09-01T00:00:00Z